Abstract
Chronic Myeloid Leukemia (CML) is one of the myeloproliferative disorders characterized by Philadelphia chromosome presence. Contrary to Western countries, most CML patients in Indonesia present symptoms with splenomegaly as the most common finding. It is rare to find asymptomatic CML patients. We present a case of asymptomatic chronic-phase chronic myeloid leukemia BCR-ABL (+) without splenomegaly who achieved a hematologic and molecular response to imatinib.
| Original language | English |
|---|---|
| Pages (from-to) | 373-375 |
| Number of pages | 3 |
| Journal | Nigerian journal of clinical practice |
| Volume | 25 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1 Mar 2022 |
Keywords
- Asymptomatic CML
- imatinib
- low to intermediate risk of ELTS and Sokal score
- molecular response